Process View
Any process that decreases the frequency, rate or extent of the chemical reactions and pathways involving hydrogen peroxide.

In addition to gene-name show these genes:
Click on a gene's description to view its network relationships with genes known to be involved in "negative regulation of hydrogen peroxide metabolic process"
| Name | Description | Probability | Func Analog Organism | |
|---|---|---|---|---|
| APOE | apolipoprotein E | 0.854 | ||
| MMP12 | matrix metallopeptidase 12 (macrophage elastase) | 0.845 | ||
| CAPN1 | calpain 1, (mu/I) large subunit | 0.798 | ||
| TIMP2 | TIMP metallopeptidase inhibitor 2 | 0.664 | ||
| THBS1 | thrombospondin 1 | 0.589 | ||
| GLRX | glutaredoxin (thioltransferase) | 0.431 | ||
| MMP14 | matrix metallopeptidase 14 (membrane-inserted) | 0.389 | ||
| MMP10 | matrix metallopeptidase 10 (stromelysin 2) | 0.371 | Human | |
| MMP3 | matrix metallopeptidase 3 (stromelysin 1, progelatinase) | 0.358 | ||
| TGFB1 | transforming growth factor, beta 1 | 0.250 | ||
| A2M | alpha-2-macroglobulin | 0.234 | ||
| MMP1 | matrix metallopeptidase 1 (interstitial collagenase) | 0.222 | Human | |
| APOA1 | apolipoprotein A-I | 0.205 | ||
| CCL7 | chemokine (C-C motif) ligand 7 | 0.167 | ||
| THBS2 | thrombospondin 2 | 0.165 | ||
| MMP13 | matrix metallopeptidase 13 (collagenase 3) | 0.141 | Human | |
| JAK1 | Janus kinase 1 | 0.091 | ||
| ITGA2 | integrin, alpha 2 (CD49B, alpha 2 subunit of VLA-2 receptor) | 0.090 | ||
| JAK2 | Janus kinase 2 | 0.088 | ||
| INHBA | inhibin, beta A | 0.076 | ||
| TIMP1 | TIMP metallopeptidase inhibitor 1 | 0.070 | ||
| IL6ST | interleukin 6 signal transducer (gp130, oncostatin M receptor) | 0.067 | ||
| MEP1A | meprin A, alpha (PABA peptide hydrolase) | 0.066 | ||
| CXCL5 | chemokine (C-X-C motif) ligand 5 | 0.062 | ||
| CXCL6 | chemokine (C-X-C motif) ligand 6 (granulocyte chemotactic protein 2) | 0.062 | ||
| LRRC15 | leucine rich repeat containing 15 | 0.058 | ||
| PIAS3 | protein inhibitor of activated STAT, 3 | 0.057 | ||
| APOC1 | apolipoprotein C-I | 0.050 | ||
| PDPN | podoplanin | 0.050 | ||
| SLC11A1 | solute carrier family 11 (proton-coupled divalent metal ion transporters), member 1 | 0.050 | ||
| DOK4 | docking protein 4 | 0.047 | ||
| IFNAR2 | interferon (alpha, beta and omega) receptor 2 | 0.046 | ||
| CORO1A | coronin, actin binding protein, 1A | 0.042 | ||
| MMP11 | matrix metallopeptidase 11 (stromelysin 3) | 0.040 | Human | |
| NCF1 | neutrophil cytosolic factor 1 | 0.038 | ||
| CHI3L1 | chitinase 3-like 1 (cartilage glycoprotein-39) | 0.035 | ||
| LAMC2 | laminin, gamma 2 | 0.034 | ||
| FAP | fibroblast activation protein, alpha | 0.033 | ||
| PTHLH | parathyroid hormone-like hormone | 0.033 | ||
| HPR | haptoglobin-related protein | 0.032 | ||
| PTAFR | platelet-activating factor receptor | 0.031 | ||
| BGN | biglycan | 0.029 | ||
| BMP1 | bone morphogenetic protein 1 | 0.029 | ||
| TGFBR2 | transforming growth factor, beta receptor II (70/80kDa) | 0.029 | ||
| CSF3R | colony stimulating factor 3 receptor (granulocyte) | 0.028 | ||
| SPP1 | secreted phosphoprotein 1 | 0.027 | ||
| POSTN | periostin, osteoblast specific factor | 0.027 | ||
| STC1 | stanniocalcin 1 | 0.027 | ||
| OSBPL10 | oxysterol binding protein-like 10 | 0.027 | ||
| MMP8 | matrix metallopeptidase 8 (neutrophil collagenase) | 0.026 | Human | |
| TNFAIP6 | tumor necrosis factor, alpha-induced protein 6 | 0.026 | ||
| COL10A1 | collagen, type X, alpha 1 | 0.025 | ||
| CCL20 | chemokine (C-C motif) ligand 20 | 0.025 | ||
| SERPINB2 | serpin peptidase inhibitor, clade B (ovalbumin), member 2 | 0.025 | ||
| MSC | musculin | 0.024 | ||
| PRKACA | protein kinase, cAMP-dependent, catalytic, alpha | 0.023 | ||
| KCNJ15 | potassium inwardly-rectifying channel, subfamily J, member 15 | 0.023 | ||
| RPS3 | ribosomal protein S3 | 0.021 | ||
| MEP1B | meprin A, beta | 0.021 | ||
| MMP9 | matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase) | 0.021 | Human | |
| SERPINA3 | serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 3 | 0.020 | ||
| LBP | lipopolysaccharide binding protein | 0.020 | ||
| PI3 | peptidase inhibitor 3, skin-derived | 0.020 | ||
| WISP1 | WNT1 inducible signaling pathway protein 1 | 0.019 | ||
| SEMA7A | semaphorin 7A, GPI membrane anchor (John Milton Hagen blood group) | 0.019 | ||
| SOCS1 | suppressor of cytokine signaling 1 | 0.019 | ||
| MFGE8 | milk fat globule-EGF factor 8 protein | 0.018 | ||
| TNFRSF10C | tumor necrosis factor receptor superfamily, member 10c, decoy without an intracellular domain | 0.018 | ||
| S100A2 | S100 calcium binding protein A2 | 0.018 | ||
| ELN | elastin | 0.018 | ||
| RETN | resistin | 0.018 | ||
| MMP19 | matrix metallopeptidase 19 | 0.017 | Human | |
| MMP2 | matrix metallopeptidase 2 (gelatinase A, 72kDa gelatinase, 72kDa type IV collagenase) | 0.017 | Human | |
| KRT16 | keratin 16 | 0.017 | ||
| ADAM12 | ADAM metallopeptidase domain 12 | 0.016 | ||
| SETD7 | SET domain containing (lysine methyltransferase) 7 | 0.016 | ||
| IL1R2 | interleukin 1 receptor, type II | 0.016 | ||
| CSF2 | colony stimulating factor 2 (granulocyte-macrophage) | 0.016 | ||
| CCL11 | chemokine (C-C motif) ligand 11 | 0.015 | ||
| TIRAP | toll-interleukin 1 receptor (TIR) domain containing adaptor protein | 0.015 | ||
| ECM1 | extracellular matrix protein 1 | 0.015 | ||
| FOLR3 | folate receptor 3 (gamma) | 0.015 | ||
| AKAP8L | A kinase (PRKA) anchor protein 8-like | 0.015 | ||
| CASP10 | caspase 10, apoptosis-related cysteine peptidase | 0.015 | ||
| WNT2 | wingless-type MMTV integration site family member 2 | 0.015 | ||
| CAPN2 | calpain 2, (m/II) large subunit | 0.014 | ||
| FGD1 | FYVE, RhoGEF and PH domain containing 1 | 0.014 | ||
| SEMA3F | sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3F | 0.014 | ||
| MMP7 | matrix metallopeptidase 7 (matrilysin, uterine) | 0.014 | Human | |
| IL11 | interleukin 11 | 0.014 | ||
| STAT5A | signal transducer and activator of transcription 5A | 0.014 | ||
| TNS3 | tensin 3 | 0.014 | ||
| PTGES | prostaglandin E synthase | 0.014 | ||
| APOA2 | apolipoprotein A-II | 0.013 | ||
| COMP | cartilage oligomeric matrix protein | 0.013 | ||
| ESM1 | endothelial cell-specific molecule 1 | 0.013 | ||
| CXCL13 | chemokine (C-X-C motif) ligand 13 | 0.013 | ||
| CEACAM8 | carcinoembryonic antigen-related cell adhesion molecule 8 | 0.013 | ||
| CLEC4E | C-type lectin domain family 4, member E | 0.013 | ||
| EPHB2 | EPH receptor B2 | 0.013 | ||
| SAA2 | serum amyloid A2 | 0.012 | ||
| DEFA4 | defensin, alpha 4, corticostatin | 0.012 | ||
| LAMC3 | laminin, gamma 3 | 0.012 | ||
| SIAH2 | seven in absentia homolog 2 (Drosophila) | 0.012 | ||
| IBSP | integrin-binding sialoprotein | 0.012 | ||
| SMO | smoothened homolog (Drosophila) | 0.012 | ||
| ACPP | acid phosphatase, prostate | 0.012 | ||
| BPI | bactericidal/permeability-increasing protein | 0.012 | ||
| IL13RA2 | interleukin 13 receptor, alpha 2 | 0.012 | ||
| MPO | myeloperoxidase | 0.012 | ||
| OLR1 | oxidized low density lipoprotein (lectin-like) receptor 1 | 0.012 | ||
| LILRA3 | leukocyte immunoglobulin-like receptor, subfamily A (without TM domain), member 3 | 0.012 | ||
| CAMP | cathelicidin antimicrobial peptide | 0.012 | ||
| EGF | epidermal growth factor | 0.012 | ||
| CP | ceruloplasmin (ferroxidase) | 0.012 | ||
| LMO2 | LIM domain only 2 (rhombotin-like 1) | 0.012 | ||
| VAV2 | vav 2 guanine nucleotide exchange factor | 0.011 | ||
| CCL22 | chemokine (C-C motif) ligand 22 | 0.011 | ||
| CSF3 | colony stimulating factor 3 (granulocyte) | 0.011 | ||
| LOXL2 | lysyl oxidase-like 2 | 0.011 | ||
| PLAU | plasminogen activator, urokinase | 0.011 | ||
| DOK6 | docking protein 6 | 0.011 | ||
| PLAUR | plasminogen activator, urokinase receptor | 0.011 | ||
| STAT2 | signal transducer and activator of transcription 2, 113kDa | 0.011 | ||
| HP | haptoglobin | 0.011 | ||
| WNT4 | wingless-type MMTV integration site family, member 4 | 0.011 | ||
| MDM2 | Mdm2 p53 binding protein homolog (mouse) | 0.011 | ||
| PRTN3 | proteinase 3 | 0.011 | ||
| MARCO | macrophage receptor with collagenous structure | 0.011 | ||
| SH2D1B | SH2 domain containing 1B | 0.011 | ||
| FFAR2 | free fatty acid receptor 2 | 0.011 | ||
| BCAN | brevican | 0.011 | ||
| AQP9 | aquaporin 9 | 0.010 | ||
| LAMB3 | laminin, beta 3 | 0.010 | ||
| IFNGR1 | interferon gamma receptor 1 | 0.010 | ||
| THY1 | Thy-1 cell surface antigen | 0.010 | ||
| CCL18 | chemokine (C-C motif) ligand 18 (pulmonary and activation-regulated) | 0.010 | ||
| ITGB3 | integrin, beta 3 (platelet glycoprotein IIIa, antigen CD61) | 0.010 | ||
| CST1 | cystatin SN | 0.010 | ||
| SLCO1B3 | solute carrier organic anion transporter family, member 1B3 | 0.010 |